Search for Clinical Trial Results

Sponsored By

Facioscapulohumeral Muscular Dystrophy - 25 Studies Found

Status Study
Active, not recruiting Study Name: Bone Health in Facioscapulohumeral Muscular Dystrophy
Condition: Facioscapulohumeral Muscular Dystrophy
Date: 2015-04-06
Recruiting Study Name: Magnetic Resonance Imaging and Spectroscopy Biomarkers for Facioscapulohumeral Muscular Dystrophy
Condition: Facioscapulohumeral Muscular Dystrophy
Date: 2012-08-21
Recruiting Study Name: Study of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD)
Condition: Facioscapulohumeral Muscular Dystrophy
Date: 2016-10-05
Interventions:
  • Drug: ACE-083 Recombinant fusi
Completed Study Name: High Intensity Training in Patients With Facioscapulohumeral Muscular Dystrophy
Condition: FSHD - Facioscapulohumeral Muscular Dystrophy
Date: 2014-06-04
Interventions:
  • Other: Supervised training 8 w
Completed Study Name: Evaluate Safety and Biological Activity of ATYR1940 in Patients With Early Onset Facioscapulohumeral Muscular Dystrophy
Condition: Facioscapulohumeral Muscular Dystrophy (FSHD)
Date: 2015-11-05
Interventions:
  • Biological: ATYR1940 ATYR1940

Completed Study Name: 1 Year MRI Followup in Facioscapulohumeral Muscular Dystrophy
Condition: FSHD - Facioscapulohumeral Muscular Dystrophy
Date: 2014-06-06
Interventions: Other: MRI MRI scan of muscles in the back and legs. Including T1, DIXON and STIR images.
Completed Study Name: Electrostimulation of Shoulder Girdle and Quadriceps Muscles in Facioscapulohumeral Muscular Dystrophy Patients
Condition: Facioscapulohumeral Muscular Dystrophy
Date: 2009-01-12
Interventions: Procedure: electrostimulation Electrostimulation of shoulder girdle and quadriceps muscles in facioscapu
Completed Study Name: Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Patients With Limb Girdle and Facioscapulohumeral Muscular Dystrophy
Condition:
  • Facioscapulohumeral Muscular Dystrophy
  • Limb Girdle Muscular Dys
    Date: 2016-06-30
    Interventions: Drug: ATYR1940 ATYR1940 at a dose no greater than 3.0 mg/kg administered via IV infusion over 90 minutes
Completed Study Name: The Safety and Biological Activity of ATYR1940 in Patients With Limb Girdle or Facioscapulohumeral Muscular Dystrophies
Condition:
  • Limb-Girdle Muscular Dystrophies
  • Facioscapulohumeral Muscular Dystroph
    Date: 2015-09-28
    Interventions:
    • Biological: ATYR1940 Intrapati
Active, not recruiting Study Name: A Multicenter Collaborative Study on the Clinical Features, Expression Profiling, and Quality of Life of Infantile Onset FSHD
Condition: Facioscapulohumeral Muscular Dystrophy
Date: 2011-09-19
Next >>>